FDA Panel Rejects Pfizer Booster Plan, Mulls Narrower One

Subscribe to The Global Herald in Google News

Bloomberg Quicktake: Now published this video item, entitled “FDA Panel Rejects Pfizer Booster Plan, Mulls Narrower One” – below is their description.

A U.S. Food and Drug Administration panel of expert advisers voted against a third dose of the Pfizer Inc.-BioNTech SE vaccine for everyone 16 and older but was considering a booster shot for a more limited population of older adults and other vulnerable populations.

The FDA had asked the advisory panel to vote on whether the safety and effectiveness data submitted by the companies support approval of a booster dose for people age 16 and up.

Bloomberg Quicktake: Now YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


Subscribe to The Global Herald in Google News

About This Source - Bloomberg QuickTake: Now

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City.

It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg QuickTake: Now:

  • Democrats’ Billionaire Tax Plan Puts About 700 People in Its Sights
  • Heavy Rainfall Brings Deadly Flooding to Sicily
  • Biden Says Today’s Republicans ‘Stand for Nothing’ While Campaigning in Virginia
  • In This Story: BioNTech

    BioNTech SE (NASDAQ: BNTX) is a German biotechnology company dedicated to the development and manufacture of active immunotherapies for a patient-specific approach to the treatment of serious diseases.

    5 Recent Items: BioNTech

  • FDA panel recommends Pfizer’s Covid vaccine for kids 5 to 11
  • Germany’s BioNTech to build Africa vaccine plant from 2022 • FRANCE 24 English
  • FDA Panel Backs Pfizer Covid Shot for Kids 5 to 11
  • How BioNTech Used Cancer Research To Create Its Covid Vaccine
  • President Biden Gets Covid-19 Booster��Shot
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • FDA panel recommends Pfizer’s Covid vaccine for kids 5 to 11
  • Germany’s BioNTech to build Africa vaccine plant from 2022 • FRANCE 24 English
  • This Morning’s Top Headlines – October 27 | Morning News NOW
  • Pfizer COVID vaccine approved for booster program in Australia | 7NEWS
  • Pfizer booster shots to be available in Queensland from November | 7NEWS
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.

    Posting....